Short-term Use of Dapagliflozin to Protect Kidney Function in CKD Patients
NCT05225077
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
600
Enrollment
OTHER
Sponsor class
Conditions
Renal Insufficiency, Chronic
Cardiac Catheterization
Percutaneous Coronary Intervention
Interventions
DRUG:
Dapagliflozin 10 MG [Farxiga]
Sponsor
Dong-A University